Government & Policy (140)

Dr. Thomas Keane, assistant secretary for technology policy and national coordinator for health IT, describes his plans for the conference and talks about TEFCA, HTI-4, HTI-5, imaging data, behavioral health exchange and more.

The phase-out of the Medicare Inpatient-Only list drives value and efficiency, but hospitals lose out on volume and revenue, says Allison Oakes, chief research officer for Trilliant Health.

Dr. Mark Zhang, acting assistant under secretary for health at the U.S. Department of Veterans Affairs, discusses the VA Puget Sound Health Care System's X_Labs and 3D-printed bone grafts.

The U.S. Food and Drug Administration's validation requirements process for drug development is a good model for healthcare artificial intelligence governance, explains Michael Abrams, managing partner at Numerof & Associates.

For the year ahead, we'll be watching for precision medicine advances, cybersecurity challenges, policy shifts and, of course, continued evolution of AI-enabled care delivery, say the editors of the HIMSS Media brands.

Innovation is central to the DEAN program, says Dr. Carolyn Clancy, assistant under secretary at the U.S. Department of Veterans Affairs, while discussing medication visibility, cross-utilizing imaging and reducing burdens through AI collaborations.

Providers in six states face new financial risks and training burdens under mandatory WISeR review, which leverages machine learning to control costs and expedite care. It's going to be "a steep learning curve," says Jeff Ladner, CPO at Onspring.

States are shaping the future of responsible AI policy with about 200 bills focused on healthcare AI use, according to the National Conference of State Legislatures' Sarah Jaromin.

Edward Marx, CEO of Marx Advisory, discusses how to combat government policy and regulation slowing AI adoption. He also details the contributions needed from the boardroom with AI projects.

Tennessee State Sen. Bo Watson says that states, not the federal government, are driving AI regulation with constituents in mind to balance supporting innovation with guarding the public trust.

Health tech companies can anticipate the logic of generative artificial intelligence using knowledge graphs, like the FDA's Elsa, when submitting product reviews, and improve the accuracy of their outputs, says Jeff Elton of ConcertAI.

Providers are concerned about whether they have contract protections against supply chain rate hikes due to tariffs, says Ralph Keiser, CEO of ArcheHealth.